Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
出版年份 2011 全文链接
标题
Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
作者
关键词
-
出版物
CANCER AND METASTASIS REVIEWS
Volume 31, Issue 1-2, Pages 143-162
出版商
Springer Nature
发表日期
2011-11-19
DOI
10.1007/s10555-011-9337-5
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- A phase II study of cediranib (AZD2171) in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: Final results of a PMH, Chicago and California consortia trial
- (2017) H. W. Hirte et al. JOURNAL OF CLINICAL ONCOLOGY
- Aflibercept (VEGF Trap) for advanced epithelial ovarian cancer (EOC) patients (pts) with symptomatic malignant ascites: Preliminary results of a pilot study
- (2017) N. Colombo et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of Ovarian Cancer Ascites on Cell Migration and Gene Expression in an Epithelial Ovarian Cancer In Vitro Model
- (2014) Liliane Meunier et al. Translational Oncology
- Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort
- (2011) R Y Zang et al. BRITISH JOURNAL OF CANCER
- Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer
- (2011) Kathryn F. McGonigle et al. CANCER
- Tumor immune surveillance and ovarian cancer
- (2011) Lana E. Kandalaft et al. CANCER AND METASTASIS REVIEWS
- Neoadjuvant intraperitoneal chemotherapy with paclitaxel for the radical surgical treatment of peritoneal carcinomatosis in ovarian cancer: a prospective pilot study
- (2011) Francisco C. Muñoz-Casares et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- TGF-β Blockade Controls Ascites by Preventing Abnormalization of Lymphatic Vessels in Orthotopic Human Ovarian Carcinoma Models
- (2011) Shan Liao et al. CLINICAL CANCER RESEARCH
- Vascular endothelial growth factor expression up-regulated by endometrial ischemia in secretory phase plays an important role in endometriosis
- (2011) Qiong-zhen Ren et al. FERTILITY AND STERILITY
- Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
- (2011) David M. O'Malley et al. GYNECOLOGIC ONCOLOGY
- Phase II Trial of docetaxel and bevacizumab in recurrent ovarian cancer within 12months of prior platinum-based chemotherapy
- (2011) R. Wenham et al. GYNECOLOGIC ONCOLOGY
- Effects of bevacizumab and pegylated liposomal doxorubicin for the patients with recurrent or refractory ovarian cancers
- (2011) Kazuya Kudoh et al. GYNECOLOGIC ONCOLOGY
- Bevacizumab Treatment for Solid Tumors
- (2011) Daniel F. Hayes JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers
- (2011) Yoshihito Yokoyama et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Big Costs for Little Gain in Ovarian Cancer
- (2011) Martee L. Hensley JOURNAL OF CLINICAL ONCOLOGY
- At What Cost Does a Potential Survival Advantage of Bevacizumab Make Sense for the Primary Treatment of Ovarian Cancer? A Cost-Effectiveness Analysis
- (2011) David E. Cohn et al. JOURNAL OF CLINICAL ONCOLOGY
- Correction: Antiangiogenic therapy: impact on invasion, disease progression and metastasis
- (2011) John M. L. Ebos et al. Nature Reviews Clinical Oncology
- Comparison of peritoneal carcinomatosis scoring methods in predicting resectability and prognosis in advanced ovarian cancer
- (2010) Elisabeth Chéreau et al. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
- Myocyte vascular endothelial growth factor is required for exercise-induced skeletal muscle angiogenesis
- (2010) I. Mark Olfert et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Influence of the vascular endothelial growth factor on the development of severe pre-eclampsia or HELLP syndrome
- (2010) Stefanie Bussen et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Angiogenesis Inhibitors: Current Strategies and Future Prospects
- (2010) K. M. Cook et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Functional significance of VEGF-a in human ovarian carcinoma: Role in vasculogenic mimicry
- (2010) Jun-yan Wang et al. CANCER BIOLOGY & THERAPY
- Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling
- (2010) Noriomi Matsumura et al. CANCER SCIENCE
- Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure
- (2010) B. Daan Westenbrink et al. CARDIOVASCULAR RESEARCH
- Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development
- (2010) Beate M. Lichtenberger et al. CELL
- Overexpression of Tumor Vascular Endothelial Growth Factor A May Portend an Increased Likelihood of Progression in a Phase II Trial of Bevacizumab and Erlotinib in Resistant Ovarian Cancer
- (2010) S. K. Chambers et al. CLINICAL CANCER RESEARCH
- Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2
- (2010) C. M. Annunziata et al. CLINICAL CANCER RESEARCH
- The role of vascular endothelial growth factor in the progression of diabetic vascular complications
- (2010) R A Mahdy et al. EYE
- A Phase II, open-label study evaluating pazopanib in patients with recurrent ovarian cancer
- (2010) Michael Friedlander et al. GYNECOLOGIC ONCOLOGY
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- A Pilot Study Evaluating a Novel Regimen Comprised of Carboplatin, Paclitaxel, and Bevacizumab for Advanced-Stage Ovarian Carcinoma
- (2010) John V. Brown et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2
- (2010) Jennifer L. Spratlin et al. JOURNAL OF CLINICAL ONCOLOGY
- Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
- (2010) Daniela Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- Addition of Bevacizumab to Chemotherapy for Treatment of Solid Tumors: Similar Results but Different Conclusions
- (2010) Alberto Ocaña et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular endothelial growth factor (VEGF) in the pathogenesis of psoriasis—A possible target for novel therapies?
- (2010) Miriam Canavese et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Clinical Significance of Serum Levels of Vascular Endothelial Growth Factor, Angiopoietin-1, and Angiopoietin-2 in Patients with Rheumatoid Arthritis
- (2010) D. KUROSAKA et al. JOURNAL OF RHEUMATOLOGY
- Binding to the Extracellular Matrix and Proteolytic Processing: Two Key Mechanisms Regulating Vascular Endothelial Growth Factor Action
- (2010) Napoleone Ferrara MOLECULAR BIOLOGY OF THE CELL
- Bridging the Gap between Cytotoxic and Biologic Therapy with Metronomic Topotecan and Pazopanib in Ovarian Cancer
- (2010) William M. Merritt et al. MOLECULAR CANCER THERAPEUTICS
- Vascular endothelial growth factor and age-related macular degeneration: from basic science to therapy
- (2010) Napoleone Ferrara NATURE MEDICINE
- Review: Molecular pathogenesis of blood-brain barrier breakdown in acute brain injury
- (2010) S. Nag et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- Astrocyte-Derived Vascular Endothelial Growth Factor Stabilizes Vessels in the Developing Retinal Vasculature
- (2010) Andrew Scott et al. PLoS One
- Role of vascular endothelial growth factor in women with PCO and PCOS: a systematic review
- (2010) Panagiotis Peitsidis et al. REPRODUCTIVE BIOMEDICINE ONLINE
- Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies
- (2010) Michael Medinger et al. Journal of Oncology
- Peritoneal carcinosis of ovarian origin
- (2010) Anna Fagotti World Journal of Gastrointestinal Oncology
- The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer
- (2009) X B Trinh et al. BRITISH JOURNAL OF CANCER
- Angiogenesis, vascular endothelial growth factor and its receptors in human surgical wounds
- (2009) I. Kumar et al. BRITISH JOURNAL OF SURGERY
- Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
- (2009) John M.L. Ebos et al. CANCER CELL
- Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
- (2009) Marta Pàez-Ribes et al. CANCER CELL
- TWEAK promotes ovarian cancer cell metastasis via NF-κB pathway activation and VEGF expression
- (2009) Lan Dai et al. CANCER LETTERS
- Novel developments in angiogenesis cancer therapy
- (2009) Hal W Hirte Current Oncology
- Local serum levels of vascular endothelial growth factor in infantile hemangioma: Intriguing mechanism of endothelial growth
- (2009) Przemysław Przewratil et al. CYTOKINE
- VEGF modulates the effects of gonadotropins in granulosa cells
- (2009) L.K. Doyle et al. DOMESTIC ANIMAL ENDOCRINOLOGY
- VEGF: A Surrogate Marker for Peripheral Vascular Disease
- (2009) A. Stehr et al. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY
- Multicellular spheroids in ovarian cancer metastases: Biology and pathology
- (2009) Kristy Shield et al. GYNECOLOGIC ONCOLOGY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Carboplatin, Paclitaxel, and Bevacizumab With Maintenance Bevacizumab As First-Line Chemotherapy for Advanced Müllerian Tumors
- (2009) Richard T. Penson et al. JOURNAL OF CLINICAL ONCOLOGY
- Vascular Endothelial Growth Factor Is Involved in Mediating Increased De Novo Hippocampal Neurogenesis in Response to Traumatic Brain Injury
- (2009) Cheol Lee et al. JOURNAL OF NEUROTRAUMA
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- Molecular Diversity of VEGF-A as a Regulator of Its Biological Activity
- (2009) Jeanette Woolard et al. MICROCIRCULATION
- Targeting Tumor Angiogenesis
- (2009) Puja Gaur et al. SEMINARS IN ONCOLOGY
- Antiangiogenic drugs in ovarian cancer
- (2008) G C Kumaran et al. BRITISH JOURNAL OF CANCER
- BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy
- (2008) F. Hilberg et al. CANCER RESEARCH
- VEGF inhibition: insights from preclinical and clinical studies
- (2008) Yongping Crawford et al. CELL AND TISSUE RESEARCH
- Maintenance Treatment with Bevacizumab Prolongs Survival in an In vivo Ovarian Cancer Model
- (2008) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- Combination gemcitabine, platinum, and bevacizumab for the treatment of recurrent ovarian cancer
- (2008) Debra L. Richardson et al. GYNECOLOGIC ONCOLOGY
- Autocrine VEGF-A/KDR loop protects epithelial ovarian carcinoma cells from anoikis
- (2008) Ifat Sher et al. INTERNATIONAL JOURNAL OF CANCER
- Functional significance of VEGFR-2 on ovarian cancer cells
- (2008) Whitney A. Spannuth et al. INTERNATIONAL JOURNAL OF CANCER
- Potential benefit of Sunitinib in recurrent and refractory ovarian clear cell adenocarcinoma
- (2008) J.A. RAUH-HAIN et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Combination Targeted Therapy With Sorafenib and Bevacizumab Results in Enhanced Toxicity and Antitumor Activity
- (2008) Nilofer S. Azad et al. JOURNAL OF CLINICAL ONCOLOGY
- Should tumor VEGF expression influence decisions on combining low-dose chemotherapy with antiangiogenic therapy? Preclinical modeling in ovarian cancer
- (2008) David O Holtz et al. Journal of Translational Medicine
- Vascular Endothelial Growth Factor Stimulates Organ-Specific Host Matrix Metalloproteinase-9 Expression and Ovarian Cancer Invasion
- (2008) D. Belotti et al. MOLECULAR CANCER RESEARCH
- Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFα in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy
- (2007) Aristotelis Bamias et al. GYNECOLOGIC ONCOLOGY
- Phase II Clinical Trial of Bevacizumab and Low-Dose Metronomic Oral Cyclophosphamide in Recurrent Ovarian Cancer: A Trial of the California, Chicago, and Princess Margaret Hospital Phase II Consortia
- (2007) Agustin A. Garcia et al. JOURNAL OF CLINICAL ONCOLOGY
- The potential role of vascular endothelial growth factor (VEGF) in cartilage
- (2007) M. Murata et al. OSTEOARTHRITIS AND CARTILAGE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now